<DOC>
	<DOCNO>NCT01330927</DOCNO>
	<brief_summary>The purpose study establish dose response relationship VA106483 nocturnal urine volume population elderly male subject Benign Prostatic Hypertrophy ( BPH ) likely present nocturia .</brief_summary>
	<brief_title>Dose Response Study VA106483 Males With Nocturia Benign Prostatic Hypertrophy ( BPH )</brief_title>
	<detailed_description>VA106483 selective vasopressin V2-receptor ( V2-receptor ) agonist develop treatment nocturia . The antidiuretic effect V2-receptor stimulation kidney well establish use peptide agonist , desmopressin , show clinical benefit diabetes insipidus , primary nocturnal enuresis nocturia . Nocturia , define wake void least per night period sleep , common complaint show age-dependent increase prevalence severity ( number nocturnal void ) . It bothersome symptom benign prostatic hypertrophy link age-dependent loss circadian release endogenous nocturnal vasopressin consequent production urine night ( nocturnal polyuria ) . Correlation nocturnal urine volume nocturnal void frequency demonstrate previous study V2-receptor agonist . The purpose study determine dose response relationship VA106483 nocturnal urine volume .</detailed_description>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Nocturia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Males age 65 year old history nocturia benign prostatic hypertrophy ( BPH ) Administration Investigational Medicinal Product ( IMP ) within 10 week entry study Any clinically significant concomitant medical disease , condition abnormal laboratory test result Other protocol define eligibility criterion may apply</criteria>
	<gender>Male</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>VA106483</keyword>
	<keyword>Nocturia</keyword>
	<keyword>Benign Prostatic Hypertrophy</keyword>
	<keyword>BPH</keyword>
	<keyword>Elderly</keyword>
	<keyword>Males</keyword>
	<keyword>Nocturnal void</keyword>
	<keyword>Anti-diuretic</keyword>
</DOC>